Now Playing

Loading streams...

Podcasts & RSS Feeds

researchRSS
All ContentRSS
View all podcasts & RSS feeds

Valley Public Radio Staff

Kristina Herrick
Kristina Herrick
Classical Music Host
George Mason
George Mason
On-air host, Clearly Classical
Rebecca Plevin
Rebecca Plevin
Reporter
Jason Scott
Jason Scott
Host, Clearly Classical and All Things Considered
Vince DiCiccio
Vince DiCiccio
Host, The Oasis; The Intersection
Ezra Romero
Ezra Romero
Reporter and Producer
Marv Allen
Marv Allen
Host, Morning Edition

Tagged: research

Pages

Just One Breath
3:17 pm
Sun October 7, 2012

Valley fever vaccine effort lacks federal funding

Share
E-mail
Comments
By YESENIA AMARO AND TRACY WOOD - Reporting on Health Collaborative

The federal government is the single biggest source for the primary research that leads to new vaccines. 

But, like the pharmaceutical industry, it currently is not supporting a valley fever vaccine. Other diseases that affect far fewer people receive much more federal support. 

Tularemia only affects about 200 people in the country annually, less than 1 percent of the estimated 150,000 people hit by valley fever. Like valley fever, the disease is primarily concentrated in only a portion of the country, mostly in the south-central and western part of the country.

Read more
Just One Breath
2:58 pm
Sun October 7, 2012

Valley fever vaccine stalls after early promise

Next imagePrevious image
Credit Photo by Brian Baer/Special To The Sacramento Bee
Dr. Demosthenes Pappagianis, the lab where he and members of his research staff are developing a Valley Fever vaccine, inside Tupper Hall at University of California, Davis.
Credit Photo by Brian Baer/Special To The Sacramento Bee
Dr. Demosthenes Pappagianis, the lab where he and members of his research staff are developing a Valley Fever vaccine, inside Tupper Hall at University of California, Davis.
Credit Photo by Brian Baer/Special To The Sacramento Bee
Dr. Demosthenes Pappagianis in the lab with his research staff inside Tupper Hall at University of California, Davis.
Share
E-mail
Comments
By YESENIA AMARO AND TRACY WOOD - Reporting on Health Collaborative

Just eight years ago, a vaccine to stop valley fever seemed within reach.

Ambitious scientists at five universities had brought in millions of dollars since 1997 from private donations and government funding to develop a way to beat the fungus before it ever had a chance to lodge in a person’s lungs and wreak havoc on his or her organs.

In 2004, they announced they had selected a pathway to pursue a vaccine.

Read more

Pages